一例因心脏性休克引起的性发作性交感性过活性的病例
Takahito Katsuyama1, Chiaki Toida1, Yasuaki Maeda1
1Department of Emergency and Critical Care Medicine Shinshu University Nagano Japan.
Acute medicine & surgery
|February 23, 2026
概括
松性交感性过活性 (PSH) 是一种过度自主激活的情况. 本病例报告详细介绍了心脏性休克患者发生的PSH,表明这两种情况之间存在联系.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 关键护理医学 关键护理医学
背景情况:
- 松性交感性多动性 (PSH) 通常与严重的脑损伤有关.
- 之前没有记录PSH在患有心脏性休克的患者身上.
- 这项研究介绍了一个患有扩张性心肌病和心脏性休克的患者的PSH病例.
研究的目的:
- 在心脏性休克的背景下报告PSH病例.
- 探索心脏性休克和PSH之间的潜在关系.
- 强调在心脏性休克患者的差异诊断中考虑PSH的重要性.
主要方法:
- 一个60岁的男性患有心脏性休克和扩张性心肌病的病例介绍.
- 监测自主症状,包括发烧,低心率,短呼吸和异常肌肉度.
- 在其他治疗证明无效后,在怀疑PSH时启动 gabapentin.
主要成果:
- 患者在入院后的第四天出现了暗示PSH的症状.
- 27日开始的 gabapentin 治疗导致 PSH 症状逐渐消失.
- 随着PSH的诊断和治疗,患者的病情有所改善.
结论:
- 在心脏性休克中,PSH可能会被大脑输液和自主性失调所触发,即使没有明显的脑损伤.
- 应考虑PSH在心脏性休克患者的差异诊断中,这些患者表现出神经发作性心力衰竭,心力衰竭和发烧.
- 及时识别和治疗PSH可以改善患者的治疗结果.
相关概念视频
Sympathetic Activation
7.1K
The sympathetic division can influence tissues and organs by releasing norepinephrine at peripheral synapses and distributing epinephrine and norepinephrine through the bloodstream. In times of crisis or stress, sympathetic activation occurs, which is regulated by sympathetic centers in the hypothalamus. As a result, sympathetic activation prepares the body for physical exertion, rapid ATP production, and heightened alertness, allowing individuals to respond effectively to challenging or...
7.1K
Disorders of the Autonomic Nervous System
1.7K
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
1.7K
Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Adrenergic Agonists: Therapeutic Uses
2.0K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.0K
Blood Pressure Imbalances and Circulatory Shock
1.7K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
553
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
553


